Pacemakers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Pacemakers Pipeline Market Report Overview

A pacemaker is a device designed to regulate the beating of the heart by providing electrical impulses delivered by the electrodes contacting the heart muscle. It can be a single chamber or dual chamber type. The pacemakers pipeline market research report provides comprehensive information about the pacemakers pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·       Dual-Chamber Pacemakers

·       Single-Chamber Pacemakers

·       Dual-Chamber Leadless Pacemakers

·       Single-Chamber Pacemakers with Leads

·       Single-Chamber Leadless Pacemakers

Key Territories ·       The US

·       China

·       Europe

·       Japan

·       New Zealand

·       Australia

·       Bangladesh

·       India

Key Regulatory Paths ·       PMA

·       CE

·       NMPA

·       Shonin

·       TGA

·       HDE Approvals

·       ICAC

Leading Companies ·       Abbott Medical

·       Arizona State University

·       Biotronik SE & Co KG

·       Boston Scientific Corp

·       Boston TransTec LLC

·       Cairdac

·       Duke University

·       Hadassah Medical Center

·       InnerPulse Inc (Inactive)

·       Kenergy Inc.

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Pacemakers Pipeline Market by Segments

The key segments in the pacemaker pipeline market are dual-chamber pacemakers, single-chamber pacemakers, dual-chamber leadless pacemakers, single-chamber pacemakers with leads, and single-chamber leadless pacemakers. As of September 2023, dual-chamber pacemakers have the highest number of pipeline products.

Pacemakers Pipeline Market Analysis by Segments, 2023 (%)

Pacemakers Pipeline Market Analysis by Segments, 2023 (%)

Buy Full Report for More Segment Insights into the Pacemakers Pipeline Market

Download A Free Report Sample

Pacemakers Pipeline Market Segmentation by Territories

Some of the key territories in the pacemaker market are the US, China, Europe, Japan, New Zealand, Australia, Bangladesh, and India. As of September 2023, the US has the highest number of pipeline products.

Pacemakers Pipeline Market Analysis by Territories, 2023 (%)

Pacemakers Pipeline Market Analysis by Territories, 2023 (%)

Buy Full Report for More Territory Insights into the Pacemakers Pipeline Market

Download A Free Report Sample

Pacemakers Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the pacemaker pipeline market are PMA, CE, NMPA, Shonin, TGA, HDE approvals, and ICAC. As of September 2023, PMA is the most followed pathway for pipeline products in the market.

Pacemakers Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Pacemakers Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy Full Report for More Regulatory Path Insights into the Pacemakers Pipeline Market

Download A Free Report Sample

Pacemakers Pipeline Market – Competitive Landscape

Some of the key companies in the pacemaker pipeline market are Abbott Medical, Arizona State University, Biotronik SE & Co KG, Boston Scientific Corp, Boston TransTec LLC, Cairdac, Duke University, Hadassah Medical Center, InnerPulse Inc (Inactive), and Kenergy Inc.

Arizona State University: It is an educational and research university that provides entrepreneurship solutions and has partnerships with private companies to advance their research. The university offers education services in the areas of design and the arts, arts, and sciences, business, engineering, graduate, health solutions, education, journalism, honors, and other sectors. It operates through its campuses in Tempe and Phoenix, the US. ASU is headquartered in Tempe, Arizona, the US.

Biotronik SE & Co KG: It is a medical device company that develops, manufactures, and distributes cardiovascular and endovascular solutions. The company’s cardiac rhythm management solutions include implantable devices, leads, and accessories and external devices to treat and manage arrhythmia-related diseases. Biotronik is headquartered in Berlin, Germany.

Pacemakers Pipeline Market Analysis by Companies, 2023

Pacemakers Pipeline Market Analysis by Companies, 2023

Buy Full Report for More Company Insights into the Pacemakers Pipeline Market

Download A Free Report Sample

Segments Covered in the Report

Pacemakers Pipeline Market Segments Outlook

  • Dual-Chamber Pacemakers
  • Single-Chamber Pacemakers
  • Dual-Chamber Leadless Pacemakers
  • Single-Chamber Pacemakers with Leads
  • Single-Chamber Leadless Pacemakers

Pacemakers Pipeline Market Territories Outlook

  • The US
  • China
  • Europe
  • Japan
  • New Zealand
  • Australia
  • Bangladesh
  • India

Pacemakers Pipeline Market Regulatory Paths Outlook

  • PMA
  • CE
  • NMPA
  • Shonin
  • TGA
  • HDE Approvals
  • ICAC

Scope

This report provides:

  • Extensive coverage of the pacemakers under development.
  • Details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities
  • Reviews of the major players involved in the development of pacemakers and list all their pipeline projects
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage
  • Key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of Pacemakers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Abbott Medical
Arizona State University
Biotronik SE & Co KG
Boston Scientific Corp
Boston TransTec LLC
Cairdac
Duke University
Hadassah Medical Center
InnerPulse Inc (Inactive)
Kenergy Inc.
Krisara Engineering, LLC
Medtronic Plc
MicroPort CRM SA
MicroPort Scientific Corp
Northwestern University
NuVascular Technologies Inc
Osypka Medical GmbH
Perpetuum Ltd
Rice University
Suzhou Singular Medical Co Ltd
Thayer School of Engineering at Dartmouth
U.S. Stem Cell Inc
University of Arizona
University of Bern
University of California Los Angeles
University of Michigan
University of Southern California

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 8

2 Introduction 9

2.1 Pacemakers Overview 9

3 Products under Development 10

3.1 Pacemakers – Pipeline Products by Stage of Development 10

3.2 Pacemakers – Pipeline Products by Segment 11

3.3 Pacemakers – Pipeline Products by Territory 12

3.4 Pacemakers – Pipeline Products by Regulatory Path 13

3.5 Pacemakers – Pipeline Products by Estimated Approval Date 14

3.6 Pacemakers – Ongoing Clinical Trials 15

4 Pacemakers – Pipeline Products under Development by Companies 16

4.1 Pacemakers Companies – Pipeline Products by Stage of Development 16

4.2 Pacemakers – Pipeline Products by Stage of Development 18

5 Pacemakers Companies and Product Overview 20

5.1 Abbott Medical Company Overview 20

5.1.1 Abbott Medical Pipeline Products & Ongoing Clinical Trials Overview 20

5.2 Arizona State University Company Overview 23

5.2.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 23

5.3 Biotronik SE & Co KG Company Overview 24

5.3.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 24

5.4 Boston Scientific Corp Company Overview 28

5.4.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 28

5.5 Boston TransTec LLC Company Overview 31

5.5.1 Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 31

5.6 Cairdac Company Overview 32

5.6.1 Cairdac Pipeline Products & Ongoing Clinical Trials Overview 32

5.7 Duke University Company Overview 33

5.7.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 33

5.8 Hadassah Medical Center Company Overview 34

5.8.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 34

5.9 InnerPulse Inc (Inactive) Company Overview 35

5.9.1 InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35

5.10 Kenergy Inc. Company Overview 36

5.10.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 36

5.11 Krisara Engineering, LLC Company Overview 37

5.11.1 Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview 37

5.12 Medtronic Plc Company Overview 38

5.12.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 38

5.13 MicroPort CRM SA Company Overview 42

5.13.1 MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview 42

5.14 MicroPort Scientific Corp Company Overview 54

5.14.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 54

5.15 Northwestern University Company Overview 55

5.15.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 55

5.16 NuVascular Technologies Inc Company Overview 56

5.16.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.17 Osypka Medical GmbH Company Overview 57

5.17.1 Osypka Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 57

5.18 Perpetuum Ltd Company Overview 58

5.18.1 Perpetuum Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

5.19 Rice University Company Overview 59

5.19.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 59

5.20 Suzhou Singular Medical Co Ltd Company Overview 60

5.20.1 Suzhou Singular Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

5.21 Thayer School of Engineering at Dartmouth Company Overview 61

5.21.1 Thayer School of Engineering at Dartmouth Pipeline Products & Ongoing Clinical Trials Overview 61

5.22 U.S. Stem Cell Inc Company Overview 62

5.22.1 U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.23 University of Arizona Company Overview 63

5.23.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 63

5.24 University of Bern Company Overview 64

5.24.1 University of Bern Pipeline Products & Ongoing Clinical Trials Overview 64

5.25 University of California Los Angeles Company Overview 65

5.25.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 65

5.26 University of Michigan Company Overview 66

5.26.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 66

5.27 University of Southern California Company Overview 67

5.27.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 67

6 Pacemakers- Recent Developments 69

6.1 Sep 01, 2023: Japan Lifeline Announces Changes in Organizations and Personnel 69

6.2 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 69

6.3 Aug 17, 2023: Mayo Clinic Reports Strong Finances for 2023 So Far with Q2 Revenue of $4.47 billion 69

6.4 Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees 69

6.5 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility 69

6.6 Jul 19, 2023: Boston Scientific Lays off 52 Amid California Facility Closure 70

6.7 Jul 12, 2023: Adventist Health Hanford Offers the World’s Tiniest Pacemakers 70

6.8 May 17, 2023: Nihon Kohden announces consolidated financial results for the fiscal year ended March 31, 2023 70

6.9 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 70

6.10 Apr 27, 2023: Integer Holdings reports First Quarter 2023 results 71

6.11 Apr 12, 2023: Medtronic has a layoff in California 73

6.12 Mar 30, 2023: Integer Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023 73

6.13 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 73

6.14 Feb 16, 2023: Integer Holdings Reports Results for Fourth Quarter and Full Year 2022 73

6.15 Feb 08, 2023: Nihon Kohden Announces Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2023 76

6.16 Feb 07, 2023: JMS Co Announces Financial Results for the 3rd Quarter of FYE March 2023 76

6.17 Feb 01, 2023: Japan Lifeline Announces Consolidated Financial Results for the Nine months Ended December 31, 2022 77

6.18 Jan 12, 2023: CVRx to Report Fourth Quarter and Fiscal Year 2022 Financial and Operating Results and Host Conference Call on January 26, 2023 78

6.19 Jan 09, 2023: CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results 78

6.20 Dec 20, 2022: CVRx Appoints Industry Veteran Kevin Hykes to Board of Directors 79

6.21 Nov 23, 2022: Medtronic Reports Quarterly Earnings 80

6.22 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 80

6.23 Nov 22, 2022: Mayo Clinic surgeon takes the wheel as Kwik Trip’s new CEO 86

6.24 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 86

6.25 Nov 09, 2022: Nihon Kohden Consolidated Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2023 86

6.26 Nov 04, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended September 2022 87

6.27 Oct 27, 2022: Integer Holdings Reports Third Quarter 2022 Results 87

6.28 Oct 19, 2022: Nihon Kohden Announces a Revision to its Forecast for Financial Results 88

6.29 Sep 30, 2022: Natalie Caine named chief administrative officer at Mayo Clinic in Rochester 89

7 Appendix 90

7.1 Methodology 90

7.2 About GlobalData 93

7.3 Contact Us 93

7.4 Disclaimer 93

Table

Pacemakers – Pipeline Products by Stage of Development 10

Pacemakers – Pipeline Products by Segment 11

Pacemakers – Pipeline Products by Territory 12

Pacemakers – Pipeline Products by Regulatory Path 13

Pacemakers – Pipeline Products by Estimated Approval Date 14

Pacemakers – Ongoing Clinical Trials 15

Pacemakers Companies – Pipeline Products by Stage of Development 16

Pacemakers – Pipeline Products by Stage of Development 18

Abbott Medical Pipeline Products & Ongoing Clinical Trials Overview 20

Aveir DR Leadless System – Product Status 20

Aveir DR Leadless System – Product Description 20

Abbott Medical – Ongoing Clinical Trials Overview 21

Aveir DR Leadless System – Aveir Dual-Chamber Leadless Pacemaker Real-World Evidence Post-Approval Study 22

Aveir DR Leadless System – The AVEIR DR Coverage With Evidence Development (DRIVE) Study 22

Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 23

Wireless Pacemaker System – Product Status 23

Wireless Pacemaker System – Product Description 23

Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 24

Amvia Stellar – Product Status 24

Amvia Stellar – Product Description 24

Solvia Rise – Product Status 25

Solvia Rise – Product Description 25

Biotronik SE & Co KG – Ongoing Clinical Trials Overview 26

Solvia Rise – BIO|CONCEPT.Amvia, First in Human Study for the Amvia/Solvia Pacemaker Family 27

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 28

EMPOWER Leadless Pacer – Product Status 28

EMPOWER Leadless Pacer – Product Description 29

INGENIO 2 PG – MICS – Product Status 29

INGENIO 2 PG – MICS – Product Description 29

Temporary RV VVI Pacemaker – Product Status 30

Temporary RV VVI Pacemaker – Product Description 30

Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 31

Raul Pacemaker – Product Status 31

Raul Pacemaker – Product Description 31

Cairdac Pipeline Products & Ongoing Clinical Trials Overview 32

Autonomous Leadless Pacing System – Product Status 32

Autonomous Leadless Pacing System – Product Description 32

Duke University Pipeline Products & Ongoing Clinical Trials Overview 33

Tissue-Engineered Autonomous Pacemaker – Product Status 33

Tissue-Engineered Autonomous Pacemaker – Product Description 33

Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 34

Aortic Pacemaker – Product Status 34

Aortic Pacemaker – Product Description 34

InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35

InnerPulse Pacemaker – Product Status 35

InnerPulse Pacemaker – Product Description 35

Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 36

Unconditional MRI Compatible Implantable Pacemaker – Product Status 36

Unconditional MRI Compatible Implantable Pacemaker – Product Description 36

Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview 37

Wireless Pacemaker – Product Status 37

Wireless Pacemaker – Product Description 37

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 38

Brady Wireless – Product Status 38

Brady Wireless – Product Description 38

Heart Pacemaker – Product Status 39

Heart Pacemaker – Product Description 39

Micra AR – Product Status 39

Micra AR – Product Description 40

Micra DDD Pacemaker – Product Status 40

Micra DDD Pacemaker – Product Description 40

Percepta Quad CRT-P MRI SureScan – Product Status 41

Percepta Quad CRT-P MRI SureScan – Product Description 41

MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview 42

Borea SR Pacemaker – Product Status 42

Borea SR Pacemaker – Product Description 43

Eno 1.5/3T Pacemaker – Product Status 43

Eno 1.5/3T Pacemaker – Product Description 43

Kora 250 Pacemaker – Product Status 44

Kora 250 Pacemaker – Product Description 44

Leadless Pacemaker – Product Status 44

Leadless Pacemaker – Product Description 45

Microport Oto Pacemaker – Product Status 45

Microport Oto Pacemaker – Product Description 45

Reply MRI Pacemaker – Product Status 46

Reply MRI Pacemaker – Product Description 46

Space MRI Pacemaker – Product Status 46

Space MRI Pacemaker – Product Description 47

Teo Pacemaker – Product Status 47

Teo Pacemaker – Product Description 47

TPG – External Temporary Pacemaker – Product Status 48

TPG – External Temporary Pacemaker – Product Description 48

MicroPort CRM SA – Ongoing Clinical Trials Overview 49

Eno 1.5/3T Pacemaker – Clinical Investigation of ENO/TEO/OTO Pacing System Under MRI Environment 50

Teo Pacemaker – Clinical Investigation of ENO/TEO/OTO Pacing System Under MRI Environment 51

Microport Oto Pacemaker – Clinical Investigation of ENO/TEO/OTO Pacing System Under MRI Environment 52

Borea SR Pacemaker – Clinical Assessment of Essential Remote Monitoring Functions in Pacemakers 53

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 54

Falcon MRI Pacemaker – Product Status 54

Falcon MRI Pacemaker – Product Description 54

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 55

Implantable Pacing Device – Product Status 55

Implantable Pacing Device – Product Description 55

NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 56

Biological Pacemaker – Product Status 56

Biological Pacemaker – Product Description 56

Osypka Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 57

PACE 300 – Product Status 57

PACE 300 – Product Description 57

Perpetuum Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

Implantable Self-Energising Pacemaker – Product Status 58

Implantable Self-Energising Pacemaker – Product Description 58

Rice University Pipeline Products & Ongoing Clinical Trials Overview 59

Battery-Less Pacemaker – Product Status 59

Battery-Less Pacemaker – Product Description 59

Suzhou Singular Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

Dual Chamber Pacemaker – Product Status 60

Dual Chamber Pacemaker – Product Description 60

Thayer School of Engineering at Dartmouth Pipeline Products & Ongoing Clinical Trials Overview 61

Self-Charging Pacemaker – Product Status 61

Self-Charging Pacemaker – Product Description 61

U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 62

BioPace – Product Status 62

BioPace – Product Description 62

University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 63

Pacemaker – Product Status 63

Pacemaker – Product Description 63

University of Bern Pipeline Products & Ongoing Clinical Trials Overview 64

Batteryless Cardiac Pacemaker – Product Status 64

Batteryless Cardiac Pacemaker – Product Description 64

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 65

Intravascular Wirelessly Powered Micro-Pacer – Product Status 65

Intravascular Wirelessly Powered Micro-Pacer – Product Description 65

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 66

Cardiac Energy Harvesting Pacemaker – Product Status 66

Cardiac Energy Harvesting Pacemaker – Product Description 66

University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 67

Fetal Micro-Pacemaker – Product Status 67

Fetal Micro-Pacemaker – Product Description 67

Micropacemaker – Product Status 68

Micropacemaker – Product Description 68

Glossary 92

Figures

Pacemakers – Pipeline Products by Stage of Development 10

Pacemakers – Pipeline Products by Segment 11

Pacemakers – Pipeline Products by Territory 12

Pacemakers – Pipeline Products by Regulatory Path 13

Pacemakers – Pipeline Products by Estimated Approval Date 14

Pacemakers – Ongoing Clinical Trials 15

Frequently asked questions

Pacemakers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Pacemakers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Pacemakers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Pacemakers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.